Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.

Weitzel, Jeffrey N; Neuhausen, Susan L; Adamson, Aaron; Tao, Shu; Ricker, Charité; Maoz, Asaf; Rosenblatt, Margalit; Nehoray, Bita; Sand, Sharon; Steele, Linda; Unzeitig, Gary; Feldman, Nancy; Blanco, Amie M; Hu, Donglei; Huntsman, Scott; Castillo, Danielle; Haiman, Christopher; Slavin, Thomas; Ziv, Elad

Weitzel, Jeffrey N; Neuhausen, Susan L; Adamson, Aaron; Tao, Shu; Ricker, Charité; Maoz, Asaf; Rosenblatt, Margalit; Nehoray, Bita; Sand, Sharon; Steele, Linda; Unzeitig, Gary; Feldman, Nancy; Blanco, Amie M; Hu, Donglei; Huntsman, Scott; Castillo, Danielle; Haiman, Christopher; Slavin, Thomas; Ziv, Elad.

Afiliación

Weitzel JN; Division of Clinical Cancer Genomics, City of Hope, Duarte, California.
Neuhausen SL; Clinical Cancer Genomics Community Research Network, Los Angeles, California.
Adamson A; Division of Biomarkers of Early Detection and Prevention, City of Hope, Duarte, California.
Tao S; Division of Biomarkers of Early Detection and Prevention, City of Hope, Duarte, California.
Ricker C; Integrative Genomics Core, City of Hope, Duarte, California.
Maoz A; Clinical Cancer Genomics Community Research Network, Los Angeles, California.
Rosenblatt M; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California.
Nehoray B; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California.
Sand S; University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California.
Steele L; Division of Clinical Cancer Genomics, City of Hope, Duarte, California.
Unzeitig G; Clinical Cancer Genomics Community Research Network, Los Angeles, California.
Feldman N; Division of Clinical Cancer Genomics, City of Hope, Duarte, California.
Blanco AM; Clinical Cancer Genomics Community Research Network, Los Angeles, California.
Hu D; Division of Biomarkers of Early Detection and Prevention, City of Hope, Duarte, California.
Huntsman S; Clinical Cancer Genomics Community Research Network, Los Angeles, California.
Castillo D; Gary Unzeitig MD Office, Laredo, Texas.
Haiman C; Clinical Cancer Genomics Community Research Network, Los Angeles, California.
Slavin T; University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California.
Ziv E; Division of General Internal Medicine, Department of Medicine, University of California at San Francisco, San Francisco, California.

Cancer ; 125(16): 2829-2836, 2019 08 15.

Article en En | MEDLINE | ID: mdl-31206626

Asunto(s)

Neoplasias de la Mama/genética; Quinasa de Punto de Control 2/genética; Proteína del Grupo de Complementación N de la Anemia de Fanconi/genética; Quinasas de la Proteína-Quinasa Activada por el AMP; Anciano; Proteínas de la Ataxia Telangiectasia Mutada/genética; Proteína BRCA2/genética; Estudios de Casos y Controles; Proteínas de Unión al ADN/genética; Femenino; Frecuencia de los Genes; Predisposición Genética a la Enfermedad; Hispánicos o Latinos; Humanos; Persona de Mediana Edad; Fosfohidrolasa PTEN/genética; Proteínas Serina-Treonina Quinasas/genética

Palabras clave

Hispanics; breast cancer; checkpoint kinase 2 (CHEK2); disparities; ovarian cancer; partner and localizer of BRCA2 (PALB2); whole-exome sequencing

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Quinasa de Punto de Control 2 / Proteína del Grupo de Complementación N de la Anemia de Fanconi Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: Cancer Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google